Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02048813 |
|---|---|
| Brief Title: | Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
| First Submitted : | January 27, 2014 |
| First Submitted that Met QC Criteria : | January 27, 2014 |
| First Posted : | January 29, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 25, 2021 |
| Last Update Posted : | September 28, 2021 |